Achillion Pharmaceuticals (ACHN)
Create an AlertAchillion Pharmaceuticals Price / Sales Ratio TTM:
5364.81 for June 19, 2013Achillion Pharmaceuticals Historical Price / Sales Ratio TTM Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 19, 2013 | 5364.81 |
| June 18, 2013 | 5282.37 |
| June 17, 2013 | 5229.62 |
| June 14, 2013 | 5077.94 |
| June 13, 2013 | 5091.13 |
| June 12, 2013 | 5157.07 |
| June 11, 2013 | 5262.59 |
| June 10, 2013 | 5453.84 |
| June 7, 2013 | 5453.84 |
| June 6, 2013 | 5506.60 |
| June 5, 2013 | 5117.51 |
| June 4, 2013 | 5110.91 |
| June 3, 2013 | 5288.97 |
| May 31, 2013 | 5500.00 |
| May 30, 2013 | 5150.48 |
| May 29, 2013 | 4906.48 |
| May 28, 2013 | 5005.40 |
| May 24, 2013 | 4998.80 |
| May 23, 2013 | 5038.37 |
| May 22, 2013 | 5104.32 |
| May 21, 2013 | 5110.91 |
| May 20, 2013 | 4979.02 |
| May 17, 2013 | 5124.10 |
| May 16, 2013 | 4985.61 |
| May 15, 2013 | 4886.69 |
| May 14, 2013 | 4814.15 |
| May 13, 2013 | 4781.18 |
| May 10, 2013 | 4688.85 |
| May 9, 2013 | 4695.44 |
| May 8, 2013 | 4563.55 |
| May 7, 2013 | 4596.52 |
| May 6, 2013 | 4622.90 |
| May 3, 2013 | 4576.74 |
| May 2, 2013 | 4497.60 |
| May 1, 2013 | 4669.06 |
| April 30, 2013 | 4972.42 |
| April 29, 2013 | 4880.10 |
| April 26, 2013 | 4880.10 |
| April 25, 2013 | 4609.71 |
| April 24, 2013 | 4609.71 |
| April 23, 2013 | 4774.58 |
| April 22, 2013 | 4926.26 |
| April 19, 2013 | 4880.10 |
| April 18, 2013 | 4919.66 |
| April 17, 2013 | 4847.12 |
| April 16, 2013 | 4781.18 |
| April 15, 2013 | 4735.01 |
| April 12, 2013 | 4866.91 |
| April 11, 2013 | 4873.50 |
| April 10, 2013 | 4972.42 |
About Price to Sales Ratio
The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.
An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More
ACHN Price / Sales Ratio TTM Benchmarks
| Companies | |
|---|---|
| Transcept Pharmaceuticals | 4.830 |
| Merrimack Pharmaceuticals | 9.503 |
| Vertex Pharmaceuticals | 11.91 |
ACHN Price / Sales Ratio TTM Rankings
| Overall |
61st percentile 6378 of 16782 |
| Sector |
49th percentile 716 of 1410 in Healthcare |
| Industry |
51st percentile 222 of 454 in Biotechnology |
ACHN Price / Sales Ratio TTM Range, Past 5 Years
| Minimum | -314.27 | Jan 7 2010 |
| Maximum | 5678.06 | Apr 2 2013 |
| Average | 487.31 |
